Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer. (Q34275072)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer. |
scientific article |
Statements
Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer (English)
Gabriel N Hortobagyi
Adel Tabchy
Vicente Valero
Tatiana Vidaurre
Yuan Qi
Luis Javier Barajas-Figueroa
Eduardo Souchon
Charles Coutant
Franco D Doimi
Nuhad K Ibrahim
Yun Gong
Kenneth R Hess
W Fraser Symmans
Lajos Pusztai
9 September 2010
1 reference
1 reference
1 reference